U.S. flag

An official website of the United States government

GTR Home > Conditions/Phenotypes > Thrombocytopenia 8, with dysmorphic features and developmental delay

Summary

Thrombocytopenia-8 with dysmorphic features and developmental delay (THC8) is an autosomal dominant syndromic disorder characterized by early-childhood onset of chronic thrombocytopenia with anisotropy and immature enlarged platelets, usually without spontaneous bleeding episodes. Affected individuals have dysmorphic facial features and variable developmental delay with speech delay and mildly impaired intellectual development (Latham et al., 2018). For a discussion of genetic heterogeneity of thrombocytopenia, see 313900. [from OMIM]

Available tests

1 test is in the database for this condition.

Genes See tests for all associated and related genes

  • Also known as: BKRNS, BNS, BRWS1, CSMH, DDS1, PS1TP5BP1, THC8, ACTB
    Summary: actin beta

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.